SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-24-000014
Filing Date
2024-02-29
Accepted
2024-02-29 10:02:22
Documents
4
Period of Report
2024-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1709218920.html 3  
1 FORM 3 wk-form3_1709218920.xml 3 2260
2 EX-24.1 powerofattorney_jpapa.htm EX-24.1 935
3 powerofattorney_jpapa001.jpg GRAPHIC 208753
4 powerofattorney_jpapa002.jpg GRAPHIC 104686
  Complete submission text file 0001367644-24-000014.txt   436493
Mailing Address C/O BLCO 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
PAPA JOSEPH C (Reporting) CIK: 0001242215 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 24699557

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)